Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Financial Flexibility Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Financial Flexibility Index of 0.85x as of September 2025. Free cash flow of CN¥609.18 Million (operating CF CN¥504.02 Million minus capex CN¥105.16 Million) represents 1% of total liabilities (CN¥719.98 Million). Also explore Chengdu Kanghong Pharmaceuticals Group C net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chengdu Kanghong Pharmaceuticals Group Co Ltd Financial Flexibility Index (2009–2025)
Historical Financial Flexibility Index trend for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. Check strategic asset allocation of Chengdu Kanghong Pharmaceuticals Group C to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Year-by-year free cash flow to debt coverage for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For the full company profile including market capitalisation, see market value of Chengdu Kanghong Pharmaceuticals Group C.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.74x | CN¥1.77 Billion | CN¥1.50 Billion | CN¥645.22 Million | ▲ +21.1% |
| 2024 | 2.26x | CN¥1.57 Billion | CN¥1.41 Billion | CN¥695.07 Million | ▲ +19.5% |
| 2023 | 1.89x | CN¥1.36 Billion | CN¥1.22 Billion | CN¥717.76 Million | ▲ +20.2% |
| 2022 | 1.57x | CN¥1.28 Billion | CN¥925.15 Million | CN¥813.85 Million | ▲ +25.9% |
| 2021 | 1.25x | CN¥1.06 Billion | CN¥494.11 Million | CN¥851.08 Million | ▲ +75.0% |
| 2020 | 0.71x | CN¥890.38 Million | CN¥273.32 Million | CN¥1.25 Billion | ▼ -51.5% |
| 2019 | 1.47x | CN¥1.78 Billion | CN¥812.15 Million | CN¥1.21 Billion | ▲ +102.0% |
| 2018 | 0.73x | CN¥809.33 Million | CN¥350.88 Million | CN¥1.11 Billion | ▼ -29.6% |
| 2017 | 1.04x | CN¥1.08 Billion | CN¥766.86 Million | CN¥1.04 Billion | ▼ -13.1% |
| 2016 | 1.19x | CN¥1.02 Billion | CN¥846.35 Million | CN¥853.27 Million | ▼ -25.0% |
| 2015 | 1.59x | CN¥597.80 Million | CN¥481.97 Million | CN¥376.19 Million | ▲ +37.0% |
| 2014 | 1.16x | CN¥381.65 Million | CN¥291.38 Million | CN¥329.11 Million | ▼ -13.6% |
| 2013 | 1.34x | CN¥410.47 Million | CN¥333.31 Million | CN¥305.69 Million | ▲ +22.5% |
| 2012 | 1.10x | CN¥411.35 Million | CN¥281.84 Million | CN¥375.39 Million | ▲ +20.8% |
| 2011 | 0.91x | CN¥326.11 Million | CN¥168.86 Million | CN¥359.58 Million | ▲ +23.7% |
| 2010 | 0.73x | CN¥268.56 Million | CN¥136.79 Million | CN¥366.21 Million | ▼ -22.0% |
| 2009 | 0.94x | CN¥266.69 Million | CN¥108.42 Million | CN¥283.73 Million | — |